|
Delayed
Nasdaq
01:00:00 20/11/2024 +04
|
5-day change | 1st Jan Change | ||
| 4.840 USD | +3.20% |
|
-.--% | - |
| 21/11/24 | Exscientia plc(NasdaqGS:EXAI) dropped from S&P Global BMI Index | CI |
| 20/11/24 | Recursion Pharmaceuticals, Exscientia Complete Business Combination | MT |
| Market Cap | 500M 661M 591M 550M 944M 64.01B 948M 6.61B 2.59B 32.64B 2.48B 2.43B 105B | P/E 2022 |
-4.55x | P/E 2023 | -4.28x |
|---|---|---|---|---|---|
| Enterprise Value | 156M 206M 184M 171M 294M 19.94B 295M 2.06B 807M 10.17B 774M 757M 32.63B | EV / Sales 2022 |
1.9x | EV / Sales 2023 | 14.2x |
| Free-Float |
36.87% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | +3.20% |
| 3 years | 3.8 |  | 7.91 |
| 5 years | 3.8 | | 25.16 |
| 10 years | 3.8 | | 30.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | 61 | 06/06/2024 | |
| Chief Tech/Sci/R&D Officer | - | 01/05/2022 | |
John Overington
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Mario Polywka
BRD | Director/Board Member | 63 | 28/09/2017 |
Robert Ghenchev
BRD | Director/Board Member | 43 | 01/05/2020 |
Elizabeth Crain
CHM | Chairman | 61 | 12/02/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.20% | -.--% | -.--% | +5.91% | 633M | |
| -2.59% | -5.70% | +39.83% | +82.45% | 72.13B | |
| +3.23% | -10.67% | +4.87% | +55.97% | 49.41B | |
| +1.56% | +1.17% | +5.15% | +33.38% | 47.24B | |
| +0.87% | -8.17% | +298.53% | +645.03% | 40.32B | |
| +0.39% | +0.65% | +28.02% | +30.24% | 42.61B | |
| +1.24% | -1.01% | +5.56% | +105.14% | 39.81B | |
| -2.13% | -1.64% | +7.51% | +50.31% | 30.52B | |
| +5.32% | +0.06% | -7.20% | -11.30% | 23.13B | |
| +3.78% | +8.33% | +18.40% | +0.33% | 21.09B | |
| Average | +1.49% | -2.14% | +40.07% | +99.75% | 36.69B | |
| Weighted average by Cap. | +0.78% | -2.86% | +47.04% | +117.36% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 27.22M 36.02M 32.17M 29.93M 51.4M 3.49B 51.62M 360M 141M 1.78B 135M 132M 5.7B | 20.08M 26.57M 23.73M 22.07M 37.91M 2.57B 38.08M 266M 104M 1.31B 99.78M 97.6M 4.21B |
| Net income | -119M -157M -140M -131M -224M -15.21B -225M -1.57B -616M -7.75B -590M -577M -24.88B | -146M -193M -173M -160M -276M -18.69B -277M -1.93B -757M -9.53B -725M -709M -30.58B |
| Net Debt | -492M -651M -581M -541M -929M -63B -933M -6.51B -2.55B -32.12B -2.44B -2.39B -103B | -344M -455M -407M -378M -650M -44.07B -653M -4.55B -1.78B -22.47B -1.71B -1.67B -72.11B |
Employees
483
- Stock Market
- Stocks
- EXAI Stock
Select your edition
All financial news and data tailored to specific country editions
